Company Presentation
ImmunOs Therapeutics AG
| Country: | Switzerland |
| Category: | Clinical Stage Biotech Company |
| Room: | Sydney |
| Date: | 23.04.2024. |
| Time: | 13:30-13:45 |
| Website: | https://www.immunostherapeutics.com/ |
| Speaker: | Reinhard Ambros , CEO and Chairman |
Company profile
ImmunOs Therapeutics AG has developed a proprietary human leukocyte antigen (HLA)-based platform to generate a novel class of biologic therapeutics for the treatment of cancer and autoimmune disease.
Its lead asset IOS-1002 is in Phase I clinical trial in solid cancer.
ImmunOs is backed by an international consortium of top-tier investors, including Gimv, Pfizer Ventures, Mission BioCapital, BioMed Partners, Samsara Biocapital and Lightspeed Venture Partners.
